Anthera Pharmaceuticals Inc (ANTH)
0.00
USD |
OTCM |
Apr 22, 16:00
Anthera Pharmaceuticals Cash from Investing (TTM): 0.358M for March 31, 2018
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2018 | 0.358M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.186M |
June 30, 2017 | -0.104M |
March 31, 2017 | -0.766M |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | -0.08M |
September 30, 2015 | 1.28M |
June 30, 2015 | 1.82M |
March 31, 2015 | 7.59M |
December 31, 2014 | 10.00M |
September 30, 2014 | 9.137M |
June 30, 2014 | 9.241M |
March 31, 2014 | -3.782M |
Date | Value |
---|---|
December 31, 2013 | -4.687M |
September 30, 2013 | -9.029M |
June 30, 2013 | -8.832M |
March 31, 2013 | -2.175M |
December 31, 2012 | -3.783M |
September 30, 2012 | 2.04M |
June 30, 2012 | 1.448M |
March 31, 2012 | 8.797M |
December 31, 2011 | 20.23M |
September 30, 2011 | 16.63M |
June 30, 2011 | 9.949M |
March 31, 2011 | -12.03M |
December 31, 2010 | -23.36M |
September 30, 2010 | -21.69M |
June 30, 2010 | -15.27M |
March 31, 2010 | 0.0308M |
December 31, 2009 | 0.0365M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |